MICA and breast cancer: In conclusion, a novel fusion protein MICA-G129R was created and demonstrated able to bind to PRLR-positive breast cancer cells and NK cells, promote the release of granzyme B and IFN-γ by NK cells and enhance the cytotoxicity to PRLR-positive breast cancer cells.